Our outcomes

Our results

Some figures about the diabetes care we provide:

Description number at 31-12-2014
Total of patients 1543
Diagnosed (primary) at Diabeter 27%
Secondary referral to Diabeter 73%
Type 1 diabetes 1438
Type 2 diabetes 8
Monogenetic diabetes (MODY) 45
Cystic fibrosis related diabetes (CFRD)Patients with pen therapy (MDI) 42
Patients with pen therapy (MDI) 634
Patients with insulin pump (CSII) 876
Pump treatment supported by glucose sensor (SAP) 127
Patients with HbA1c below 58 mmol/ml (7,5%)  
* 0 - 6 years 58%
* 6 - 12 years 69%
* 12 - 18 years 46%
* Older than 18 year 57%
Patients with HbA1c over 86 mmol/mol (10%)  
* 0 - 6 years 0%
* 6 - 12 years 1%
* 12 - 18 years 6%
* Older than 18 years 5%
Admission to hospital average: 3%
* 0 - 6 years 0%
* 6 - 12 years 3%
* 12 - 18 years 5%
* older than 18 years 1%
 

Average HbA1c levels

The average glucose measurement over a period of two to three months can be measured in the blood via the so-called HbA1c levels. The national set value for children and young adults is lower than 7,5% (58 mmol/mol). For adults this is lower than 7%. 58,4% of our patients had an insulin pump in 2012. Of these patients 36,8% reached a HbA1c level between 7,5 and 9,5% and 19,4% even reached a HbA1c lower than 7%. Patients who used both a pump and a sensor gained even better results. Of them 58,5% reached an average HbA1c level lower than 7,5% and 31,7 % of this patient group even managed an average HbA1c level of less than 7%.

The results Diabetes reaches compared to international data (no Dutch national date are available) are good. But it is not only our HbA1c levels that are lower on average. The same goes for the percentage of our patients that needs to be submitted to hospital care for acute diabetes related problems. With an average of just 3% diabetes related hospital submissions per year in relation to a national average of 20% we clearly make the difference.